FDA-Drug2019-07-17Class II
LOSARTAN POTASSIUM 100 mg TABLET BULK 90 count bottles, NDC 00591-3747-00
Teva Pharmaceuticals USA
Hazard
CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.
Sold states
Nationwide by 4 major distributors.
Affected count
2,943,000 tablets
Manufactured in
400 Interpace Pkwy, Parsippany, NJ, United States
Products
LOSARTAN POTASSIUM 100 mg TABLET BULK 90 count bottles, NDC 00591-3747-00
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1456-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief